A 1 adenosine receptor agonists

Details A 1 adenosine receptor agonists A 1 adenosine receptor agonists

2006-10-11

2009-02-10

McIntosh, III, Traviss C (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S045000, C536S027100, C536S027130, C536S027300, C536S027600, C536S027620

Reexamination Certificate

active

07488720

ABSTRACT:
Disclosed are novel compounds that are A1adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, diseases related to release of nonesterified fatty acids, and myocardial infarction.

REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 4326525 (1982-04-01), Swanson et al.
patent: 4902514 (1990-02-01), Barclay et al.
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5023252 (1991-06-01), Hseih
patent: 5616345 (1997-04-01), Geoghegan et al.
patent: 6326359 (2001-12-01), Monaghan et al.
patent: 2003/0013675 (2003-01-01), Yeadon et al.
patent: WO 00/23457 (2000-04-01), None
patent: WO 02/094273 (2002-11-01), None
patent: WO 03/014137 (2003-02-01), None
patent: WO 2004/069185 (2004-08-01), None
Ohno et al., “Modulation of adenosine receptor afinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position”, Bioorganic and Medicinal Chemistry, vol. 12, 2004, 2995-3007.
Dhalla et al., “Pharmacology and Therapeutic Applications of A1 Adenosine Receptor Ligands”, Current Topics in Medicinal Chemistry, 3(4) 369-385, 2003.
Adenosine A2BReceptors as Therapeutic Targets, Feoktistov et al., Trends Pharmacol Sci 19:148-153, Apr. 1998.
B. Lerman et al.Cardiac Electrophysiology of AdenosineCirculation, vol. 83 (1991), p. 1499-1509.
J. C. Shryock et al.Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and PharmacologyThe Am. J. Cardiology, vol. 79 (1997) p. 2-10.
E. A. van Schaick et al.Physiological Indirect Effect Modeling of the Antilipolytic Effects of Adenosine A1-Receptor AgonistsJ. Pharmacokinetics and Biopharmaceutics, vol. 25 (1997) p. 673-694.
P. StrongSuppression of Non-asterified Fatty Acids and Triacylglycerol in Experiental Animals by the Adenosine AnalogueClinical Science vol. 84 (1993) p. 663-669.
Thiebaud et al.Effect of Long Chain Triglyceride Indusion on Glucose Metabolism in ManMetab. Clin. Exp. vol. 31 (1982) p. 1128-1136.
G. Boden et al.Mechanisms of Fatty Acid-Induced Inhibition of Glucose UptakeJ. Clin. Invest. vol. 93 (1994) p. 2438-2446.
P. J. Randle et alThe Glucose Fatty-acid CycleThe Lancet (1963) p. 785-789.
R. B. Clark et al.Partial Agonists and G Protein-coupled Receptor DesensitizationTiPS, vol. 20 (1999) p. 279-286.
Gierschik et al.,Signal Amplification in HL-60 Granulocytes1991 p. 725-732.
Gierschik et al.,Contribution of Nucleoside Diphosphokinase to Guanine Nucleotide Regulation of Agonist Binding to Formyl Peptide Receptors1991 p. 17-23.
Lorenzen et al.,Affinity of Central Adenosine A1 Receptors is Decreased in Spontaneously Hypertensive Rats1993 p. 223-230.
Traynor & Nahorski,Mosulation by u-Opioid Agonists of Guanosine-5′-O-(3-[35S]thio)triphosphate Binding to Membranes from Human Neuroblastoma SH-SY-5Y5Y Cells1995 p. 848-854.

Affiliated with

Also associated with

Rating

A 1 adenosine receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A 1 adenosine receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A 1 adenosine receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4078454